
Recovery and Risk Define the Transit Bus Market in 2025
A 5% rise in deliveries and a surge in zero-emission buses signaled progress in 2025, but high costs, long lead times, and shifting funding priorities continue to cloud the outlook.
Read More →
A 5% rise in deliveries and a surge in zero-emission buses signaled progress in 2025, but high costs, long lead times, and shifting funding priorities continue to cloud the outlook.
Read More →
The Safety Advisory recommends that transit agencies develop and implement procedures and practices consistent with all applicable guidance and information provided by the CDC and OSHA.
Read More →
Comfort joins Managing Editor Alex Roman for the latest installment of the METROspectives podcast.
Read More →
With $25 billion on the table for transportation, cities and transit agencies have a lot of questions about the new CARES bill. We have answers.
Read More →
Inez Evans was selected as IndyGo’s president and CEO in the summer of 2019, replacing Michael Terry, who led the agency for more than 11 years.
Read More →
Fear, particularly when it’s sustained over a period of time, reorganizes the brain, cutting off the normal pathways to problem-solving.
Read More →
Schetky died after his cancer diagnosis became unmanageable, said his sons David and Chase, both VPs for the company.
Read More →
During the webinar, which is now available on demand, Morgan Lyons discussed how to plan for a crisis, as well as how look ahead once the nation can get through the pandemic, before being joined by the transit CEOs.
Read More →
Masks will be fastened to the back of the bus via a dispenser as riders enter, no contact will be required to retrieve a mask.
Read More →
The agency is now working toward launching two more lines, revamping its bus system and implementing new technologies and service models.
Read More →
For bus transit operators, potential sources of exposure include having close contact with a bus passenger with COVID-19 or by contacting surfaces touched or handled by a person with COVID-19.
Read More →